Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

PHASE4RecruitingINTERVENTIONAL
Enrollment

5,076

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

July 1, 2029

Conditions
NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)Acute Myocardial Infarction (AMI)
Interventions
DRUG

Aspirin

Aspirin bolus of 300 mg followed by 75 mg daily until CAG

DRUG

Fondaparinux Sodium

Fondaprinux 2.5 mg subcutaneus daily until CAG (1.5 mg for patients with eGFR 20-50 ml/min/1.73m2)

Trial Locations (1)

8200

RECRUITING

Aarhus University Hospital, Department of Cardiology, Aarhus N

All Listed Sponsors
collaborator

Danske Regioner

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Randers Regional Hospital

OTHER

collaborator

Viborg Regional Hospital

OTHER

collaborator

Regional Hospital Gødstrup

UNKNOWN

collaborator

Sydvestjysk Hospital Esbjerg

UNKNOWN

collaborator

Lillebaelt Hospital, Kolding and Vejle, Denmark

UNKNOWN

collaborator

Hospital of Southern Jutland

OTHER

collaborator

Horsens Hospital

OTHER

lead

University of Aarhus

OTHER